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http://www.hqlo.com/content/12/1/174RESEARCH Open AccessQuality of life after pulmonary embolism:
validation of the French version of the PEmb-QoL
questionnaire
Mathilde Rochat1*, Marie Méan2, Andreas Limacher3, Olivier Hugli4, Frederikus A Klok5, Danny M Cohn6
and Drahomir Aujesky2Abstract
Background: The PEmb-QoL is a validated 40-item questionnaire to quantify health-related quality of life in patients
having experienced pulmonary embolism (PE). It covers six health dimensions: frequency of complaints, activities of
daily living limitations, work-related problems, social limitations, intensity of complaints, and emotional complaints.
Originally developed in Dutch and English, we sought to prospectively validate the psychometric properties of a
French version of the PEmb-QoL.
Methods: We performed a forward and backward translation of the English version of the PEmb-QoL into French.
French-speaking consecutive adult patients with an acute, objectively confirmed PE admitted to the emergency
department of a Swiss university hospital between 08/2009 and 09/2011 were recruited telephonically. We used
standard psychometric tests and criteria to evaluate the acceptability, reliability, and validity of the French version of
the PEmb-QoL. We also performed an exploratory factor analysis.
Results: Overall, 102 patients were enrolled in the study. The French version of the PEmb-QoL showed good reliability
(internal consistency, item–total and inter-item correlations), reproducibility (test-retest reliability), and validity
(convergent, discriminant) in French-speaking patients with PE. The exploratory factor analysis suggested three
underlying dimensions: limitations in daily activity (items 4b-m, 5a-d), symptoms (items 1a-h and 7), and emotional
complaints (items 9a-f and j).
Conclusion: We successfully validated the French version of the PEmb-QoL questionnaire in patients with PE. Our
results show that the PEmb-QoL is a valuable tool for assessing health-related quality of life after PE in French-speaking
patients.Introduction
Acute venous thromboembolism (VTE), defined as deep
vein thrombosis (DVT) and/or pulmonary embolism (PE),
is common and has a high impact on morbidity, mortality,
and costs of care [1,2]. Besides the transient discomfort re-
lated to acute VTE, health-related quality of life is sub-
stantially influenced by the development of VTE-related
complications [3]. The long-term natural course in pa-
tients surviving an acute VTE event can be complicated
by recurrent episodes of VTE, bleeding complications
caused by anticoagulation treatment, the post-thrombotic* Correspondence: Mathilde.Rochat@chuv.ch
1Department of Internal Medicine, Lausanne University Hospital, CHUV, Rue
du Bugnon 46, 1011 Lausanne, Switzerland
Full list of author information is available at the end of the article
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Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.syndrome and in rare cases, chronic thromboembolic pul-
monary hypertension [4,5].
Disease-specific quality of life questionnaires are neces-
sary to better detect treatment effects and change over
time in patients having the same disease. While instru-
ments to measure disease-specific quality of life exist for
patients with DVT [6], the Pulmonary Embolism Quality
of Life (PEmb-QoL) questionnaire was only recently de-
veloped to specifically address health-related quality of life
in patients having experienced PE [7,8].
The PEmb-QoL, originally developed in Dutch and
translated into English, is a 40-item questionnaire thatLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tient’s perspective over the past four weeks [7,8]. A study
using the Dutch version of the PEmb-QoL found that pa-
tients with PE had an impaired quality of life compared
to the age-matched general population [9]. Recently, a
Norwegian version of the PEmb-QoL was successfully val-
idated [10]. Given that the PEmb-QoL questionnaire is
the only available validated instrument to assess QoL after
PE [8], we aimed to prospectively validate the psychomet-
ric properties of a French version of the PEmb-QoL ques-
tionnaire (Additional file 1).Methods
PEmb-QoL questionnaire
The PEmb-QoL questionnaire contains nine questions (40
items) covering six dimensions: frequency of complaints
(Q1, 8 items), activities of daily living limitations (Q4, 13
items), work-related problems (Q5, 4 items), social limita-
tions (Q6, 1 item), intensity of complaints (Q7 and Q8, 1
item each), and emotional complaints (Q9, 10 items). Re-
sponses are rated on a Likert response scale.
Because no French version of this questionnaire is avail-
able, we performed a forward-backward translation from
the English version of the PEmb-QoL questionnaire into
French according to previous published recommendations
[11]. In a first step, two independent native French
speakers, of whom one was a naïve translator without
medical background, performed a forward translation
from the original English version into French. In a second
step, two naïve English speakers performed a backward
translation into English. A committee of three experts
reviewed all translations and reached a consensus on any
discrepancy. The final French version is shown in the sup-
plemental online appendix.Scoring the PEmb-QoL questionnaire
The scales of Q1, Q4, Q5, and Q9 were reversed, with a
low point score indicating a better quality of life. Two
questions (Q2 ‘At what time of day are your lung symp-
toms most intense?’ and Q3 ‘Compared to one year ago,
how would you rate the condition of your lungs in general
now?’) were not scored. Item 4a was considered missing if
the answer was ‘I do not work’. As described in the initial
publication [8], the PEmb-QoL dimension scores were
calculated by taking the mean of the constituting items.
Dimension scores were then transformed to a scale from
0–100 to make them comparable across dimensions, with
higher scores indicating worse outcome. To estimate the
overall impact of PE on quality of life, we developed a
PEmb-QoL summary score. In a first step, we transformed
all item scores to a scale ranging from 0 to 100. In a sec-
ond step, we averaged these transformed scores (except
items Q2 and Q3) to obtain an overall summary score.Study subjects
We identified consecutive patients aged >18 years with
an acute, objectively confirmed PE admitted at the
emergency department of the Lausanne university hos-
pital, Switzerland, from August 1, 2009 to September 30,
2011 using the hospital’s electronic patient tracking sys-
tem. The confirmation of PE was based on either a high-
probability ventilation-perfusion lung scan or a positive
computed tomography scan [12,13]. We telephonically in-
vited all screened patients who survived the PE episode
for study participation. Exclusion criteria were refusal to
participate, insufficient spoken language ability in French,
history of dementia based on chart review, and residence
in a nursing home or outside Switzerland.
We chose a sample size of 100 patients to validate the
French version of the PEmb-QoL questionnaire, which
is in accordance with methodological recommendations
[14,15] and a previous similar validation study [16]. The
local ethics committee (Commission cantonale (VD)
d’éthique de la recherche sur l’être humain) approved
the study and all patients provided written consent.
Data collection
Eligible, consenting patients received a baseline PEmb-
QoL and a French language version of the Short-Form
Health Survey (SF-36) questionnaire per mail [17]. The
SF-36 questionnaire is a well validated generic quality of
life measure consisting of 36 items grouped into eight di-
mensions (physical functioning, social functioning, phys-
ical role functioning, emotional role functioning, mental
health, vitality, bodily pain, and general health). The scores
vary from 0 to 100 for each dimension, with higher values
indicating better health [18,19]. The SF-36 also provides a
physical and mental health summary score. Standardized
dimension and summary scores of the SF-36 question-
naire were calculated using the U.S. 1998 reference popu-
lation [20].
Patients were asked to complete and return both ques-
tionnaires using a pre-stamped return envelope. Partici-
pants were then mailed a second PEmb-QoL and SF-36
questionnaire ten days after the baseline evaluation. In
case a patient returned an incomplete questionnaire, a
study collaborator contacted the patient by telephone to
complete all missing items.
We used patient medical records to collect the following
baseline characteristics for all enrolled patients: age, gen-
der, cardiopulmonary comorbidity (defined as any cardiac
disease with systolic or diastolic ventricular dysfunction or
any obstructive or restrictive pulmonary disease), active
cancer (defined as cancer with ongoing oncologic or pal-
liative treatment within the previous six months), obesity
(defined as body mass index more than 30 kg/m2), history
of prior VTE, and the time interval between the index PE
and study inclusion.
Table 1 Baseline patient characteristics (n = 102)
Characteristic n (%) or median (range)
Age, years 63 (26–93)
Female gender 40 (39)
Obesity* 13 (13)
Active cancer 10 (10)
Cardiopulmonary comorbidity† 13 (13)
History of venous thromboembolism 18 (18)
Central pulmonary embolism 10 (10)
Time since pulmonary embolism (months) 15 (5–23)
*Body mass index >30 kg/m2.
†Any cardiac disease with systolic or diastolic ventricular dysfunction or any
obstructive or restrictive pulmonary disease.
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We used standard statistical tests and criteria to evaluate
the acceptability, reliability, and validity of the PEmb-QoL
[6,14,16]. Baseline characteristics were shown as propor-
tions or medians and ranges, as appropriate. The trans-
formed PEmb-QoL dimension scores were depicted in a
box plot as medians with interquartile range (IQR).
Because acceptability affects the quality of the data
obtained, it was assessed by examining completeness of
data and score distribution. To examine floor and ceiling
effects, we calculated the proportion of patients who
achieved the lowest or highest possible score per dimen-
sion and in the overall PEmb-QoL summary score. Cri-
teria for acceptability included <15% floor and ceiling
effects for dimensions and summary score [14].
Factor analysis is widely used to evaluate whether
questionnaire items can be grouped into clusters repre-
senting different dimensions of the construct under study
[21]. Because the factor analysis in the validation study by
Klok et al. [8] did not explore the appropriate number of
latent factors (underlying dimensions) but rather sought
to confirm the pre-specified structure of the questionnaire
based on six dimensions, we explored the number of
underlying dimensions and grouping of items in an ex-
ploratory factor analysis. We used the principal factor
method to analyze the correlation matrix and applied an
orthogonal varimax rotation on the loading matrix. The
number of retained factors was determined by a scree test
[22], which suggested three latent factors with eigenvalues
of 17.0, 3.9, and 1.7. After rotation, the three factors
accounted for 35%, 22%, and 19% of the total variance, re-
spectively. Question 4a (‘Do your lung symptoms now
limit you in daily activities at work?’) was omitted from
the factor analysis because almost half of patients in our
sample did not work. An item was considered to load on a
given factor if the loading was >0.3 for this factor.
We assessed reliability by determining internal consis-
tency, which was measured by Cronbach’s alpha, average
inter-item correlation, item-total correlation, and the
association between dimensions of the PEmb-QoL scores
using pairwise Spearman correlation coefficients. Internal
consistency refers to the extent to which items compris-
ing the score measure the same construct (i.e., homogen-
eity of the score), and was considered acceptable when
Cronbach’s alpha was between 0.7 and 0.95 [14]. We
regarded an item-total correlation >0.2 and an average
inter-item correlation >0.3 as good [23].
We tested reproducibility by repeating the PEmb-QoL
questionnaire after ten days (test-retest reliability). Test-
retest reliability measures the degree to which repeated
measurements applied to the same individuals provide
similar answers. We decided that a time period of ten days
between the repeated distributions of the questionnaireswas long enough to prevent recall bias but short
enough to ensure that a clinical change in the symp-
toms being measured was unlikely to occur. Test-retest
reliability was expressed as an intra-class correlation
coefficient, with values >0.7 indicating good test-retest
reliability [14].
Construct validity refers to the extent to which PEmb-
QoL scores relate to other measures in a manner consist-
ent with theoretically derived hypotheses [14]. We first
assessed construct validity by calculating pairwise Spear-
man correlation coefficients between PEmb-QoL and SF-
36 dimension and summary scores (convergent validity),
as done in previous studies [7,8]. Because both question-
naires were developed to assess health-related quality
of life, we assumed that the two measures would be
correlated in a moderate range, one being a disease-
specific and the other a generic health-related quality
of life questionnaire.
We assessed discriminant validity by examining whether
PEmb-QoL scores were correlated with measures of unre-
lated constructs, i.e. patient age, sex, and clinical charac-
teristics (obesity, cancer, and cardiopulmonary diseases).
A similar approach was used in previous studies examin-
ing discriminant validity of a similarly structured quality
of life questionnaire for DVT [6,16]. Our hypothesis was
that correlation with age, gender, and clinical characteris-
tics would be weak.Results
Patient sample
Of 242 patients with PE screened, 61 could not be
reached, 42 refused to participate, 20 had dementia, 8
lived in a nursing home, 6 were unable to speak French,
and 3 lived abroad, leaving a final study sample of 102 pa-
tients. Overall, 46 patients (45%) were aged ≥65 years, and
39% were women (Table 1). The median (range) time be-
tween occurrence of the index PE and study enrollment
was 15 (5–23) months.
Table 2 Floor and ceiling effects of the PEmb-QoL
dimension and summary scores
Floor effect* Ceiling effect†
Percent
Frequency of complaints (Q 1) 25 0
Activities of daily living limitations (Q 4) 20 0
Work-related problems (Q 5) 60 18
Social limitations (Q 6) 66 2
Intensity of complaints (Q 7 and Q 8) 20 0
Emotional complaints (Q 9) 13 0
PEmb-QoL summary score 3 0
*Indicates the percentage of patients with the lowest possible score, i.e., with
the best quality of life.
†Indicates the percentage of patients with the highest possible score, i.e., with
the lowest quality of life.
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Acceptability
All questionnaires were returned by participants (response
rate 100%). We contacted 33 participants (32%) by phone
to complete missing items. Overall, 41 participants (40%)
answered ‘I do not work’ for the question Q4a.
The median PEmb-QoL dimension and overall sum-
mary scores are shown in Figure 1. All dimensions had
floor effects, ranging from 13% for emotional complaints
(Q9) to 66% for social limitations (Q6) (Table 2). Ceiling
effects were ≤2% for all dimensions except for work-
related problems (18%).
Factor analysis
We explored the number of underlying dimensions and
grouping of items in an exploratory factor analysis,
which suggested three latent factors (dimensions): limi-
tations in daily activity (items 4b-m, 5a-d), symptoms
(items 1a-h and 7), and emotional complaints (items 9a-f
and j) (Table 3). Three items were not clearly assignable to
a meaningful dimension in the French version of the
PEmb-QoL: item 6 (“During the past four weeks, to what
extend have your lung symptoms interfered with your
normal social activities with family, friends, neighbors, or
groups?”), item 8 (“How much breathlessness have you ex-
perienced in the past four weeks?”) and item 9 g-i (“How
much of the time during the past four weeks (g) did you
feel that you were a burden to your family and friends, (h)Figure 1 Box plot of PEmb-QoL dimension and summary scores.
Median transformed scores were 9.4 (interquartile range [IQR] 3.1-21.9)
for frequency of complaints (FC), 15.4 (IQR 3.8-41.7) for activities of
daily living limitations (AL), 0.0 (IQR 0.0-50.0) for work-related problems
(WP), 0.0 (IQR 0.0-25.0) for social limitations (SL), 20.0 (IQR 10.0-40.0) for
intensity of complaints (IC), 14.0 (IQR 6.0-34.0) for emotional complaints
(EC), and 14.7 (IQR 5.9-36.3) for the PEmb-QoL summary score (PEmb).were you afraid to exert yourself, (i) did you feel limited in
taking a trip?”).
Reliability and reproducibility
Almost all Cronbach’s alpha coefficients were >0.9 ex-
cept one (intensity of complaints, 0.7), indicating high
internal consistency (Table 4). Items were positively cor-
related with each other, with all average inter-item corre-
lations >0.3. All item-total correlation values were >0.2,
ranging from 0.53 to 0.92 (data not shown for individual
items). PEmb-QoL dimensions were moderately well
correlated between themselves (0.53 ≤ r ≤0.83), with the
highest correlation being between intensity of com-
plaints and frequency of complaints (r = 0.83) and be-
tween intensity of complaints and emotional complaints
(r = 0.75). Intra-class correlation coefficients for the test-
retest analysis were high, ranging between 0.85 for social
limitations and 0.96 for emotional complaints (Table 5).
Construct validity (convergent, discriminant)
We did a correlation analysis using SF-36 component
scores to assess convergent validity of the PEmb-QoL di-
mension and overall summary scores. The PEmb-QoL di-
mensions activities of daily living limitations, work-related
problems, social limitations, and intensity of complaints
showed higher correlations with the SF-36 Physical Com-
ponent Summary, whereas frequency of complaints and
emotional complaints had higher correlations with the SF-
36 Mental Component Summary (Table 6). Overall, these
correlations supported a good convergent validity. The
PEmb-QoL dimension and overall summary scores were
only weakly correlated with clinical characteristics, indi-
cating a good discriminant validity (Table 7).
Discussion
In our validation study, the PEmb-QoL questionnaire
showed not only a high internal consistency and inter-
item and item-total correlation but also high test-retest
Table 3 Factor analysis of the PEmb-QoL questionnaire*
Factor 1 Factor 2 Factor 3
Item Factor loadings†
1a Pain behind or between the shoulder blades? 0.1031 0.6572 0.0632
1b Pain on or in the chest? 0.0770 0.7807 0.2031
1c Pain in the back? 0.2416 0.6543 0.1467
1d Sensation of pressure? 0.2262 0.6425 0.2495
1e Feeling that there is “still something there”? 0.2990 0.6354 0.2826
1f “Burning sensation” in the lung? 0.09300 0.7339 0.2218
1 g “Nagging feeling”? 0.1382 0.7831 0.2318
1 h Difficulty in breathing or breathlessness? 0.4637 0.5088 0.3665
4b Daily activities at home 0.7796 0.3230 0.2529
4c Social activities 0.7123 0.1880 0.2811
4d Vigorous activities 0.7471 0.2588 0.1131
4e Moderate activities 0.8412 0.1479 0.1001
4f Lifting or carrying activities 0.8319 0.1576 0.1946
4 g Climbing several flights of stairs 0.7851 0.2177 0.2789
4 h Climbing one flight of stair 0.8031 0.0575 0.2114
4i Bending, kneeling, or squatting 0.6167 0.1355 −0.0389
4j Walking more than half a mile 0.8121 0.1190 0.0929
4 k Walking a couple of hundred yards 0.8235 −0.0700 0.0380
4 l Walking about one hundred yards 0.6313 −0.0149 0.0573
4 m Washing or dressing yourself 0.6052 −0.0302 0.1083
5a Cut down the amount of time you spent on work or other activities 0.5441 0.2653 0.3327
5b Accomplished less than you would like 0.5570 0.3432 0.3364
5c Were limited in the kind of work or other activities 0.5898 0.3545 0.3838
5d Had difficulty performing the work or other activities 0.5865 0.3976 0.3608
6 Interference with normal social activities 0.4729 0.5088 0.4595
7 Intensity of pain around shoulder blades or in chest 0.1619 0.7540 0.3329
8 Intensity of breathlessness 0.5201 0.3874 0.5030
9a Worried about having another pulmonary embolism? −0.0201 0.2722 0.7017
9b Felt irritable? 0.2748 0.3324 0.7112
9c Worried if having to stop anticoagulant medication? −0.0401 0.1433 0.5288
9d Became emotional more readily? 0.2299 0.1613 0.8114
9e Bothered becoming emotional more readily? 0.2305 0.2645 0.7739
9f Were depressed or in low spirits? 0.3078 0.4111 0.5902
9 g Felt being a burden to family and friends? 0.5021 0.3905 0.4279
9 h Were afraid to exert yourself? 0.5391 0.4042 0.4742
9i Felt limited in taking a trip? 0.6300 0.3516 0.4126
9j Were afraid of being alone? 0.3926 0.1675 0.6115
*The scree test suggests three latent factors with eigenvalues of 17.0, 3.9, and 1.7, respectively. After rotation, the three factors accounted for 35%, 22%, and 19%
of total variance.
†Numbers in bold indicate the highest factor loadings (>0.3) for each item.
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QoL and the SF-36 and the low correlation between
PEmb-QoL scores and patient characteristics supported
convergent and discriminant validity, respectively. Thus, theFrench version of the PEmb-QoL questionnaire met stand-
ard criteria of reliability and validity for use as a patient-
reported measure of outcome in patients with PE, as
previously shown for the Dutch version of the questionnaire.
Table 4 Internal consistency reliability
PEmb-QoL questions Number of items Cronbach’s alpha Average inter-item correlation (r)
Frequency of complaints Q1 8 0.90 0.52
Activities of daily living limitations Q4 13 0.95 0.60
Work-related problems Q5 4 0.91 0.72
Social limitations Q6 1 - -
Intensity of complaints Q7, Q8 2 0.70 0.54
Emotional complaints Q9 10 0.92 0.52
PEmb-QoL summary score Q1, Q4, Q5, Q6, Q7, Q8, Q9 38 0.92 0.44
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substantial ceiling effect, with 18% of patients scoring
the maximum score (lowest possible quality of life) in
this dimension. In contrast, a substantial floor effect was
present in five out of six PEmb-QoL dimensions, i.e.
more than 15% of patients had the lowest score possible,
indicating the best possible quality of life. We could not
exclude the possibility that the Likert scale used did not
have a large enough range to accommodate the distribu-
tion of the data or that there was a social desirability
bias (i.e., patients thought it made them look better if
they reported high quality of life). The exceptionally high
floor effect (66%) of social limitations could be explained
by the fact that this dimension consists of a single ques-
tion only. Given that Klok et al. [8] already observed
such floor and ceiling effects in some of the PEmb-QoL
dimensions, we presumed that the floor and ceiling ef-
fects were not specifically related to the French version
of the PEmb-QoL questionnaire. Indeed, floor effects
>15% were also observed in all six dimensions in the
Norwegian version of the PEmb-QoL [10].
When correlating the PEmb-QoL and the SF-36 di-
mensions, we found a particularly strong correlation be-
tween activities of daily living limitations and physical
functioning, and between work-related problems and
physical role functioning. A similar observation had
been made by Klok et al. [8] and might be explained by
the fact that these dimensions focus on the extent of
limitations when performing work or physical exercises.
The relatively strong correlation between emotionalTable 5 Test-retest reliability
Intra-class correlation coefficient
(95% confidence interval)
Frequency of complaints 0.94 (0.92-0.96)
Activities of daily living limitations 0.91 (0.87-0.94)
Work-related problems 0.88 (0.84-0.93)
Social limitations 0.85 (0.79-0.90)
Intensity of complaints 0.93 (0.90-0.95)
Emotional complaints 0.96 (0.94-0.97)
PEmb-QoL summary score 0.96 (0.95-0.98)complaints and social and emotional role functioning
and mental health did not come as a surprise, either.
The correlation between intensity of complaints and
bodily pain was clinically also plausible.
The six dimensions of the PEmb-QoL were originally
defined clinically and not statistically, assuming that
these six dimensions would provide unique information
to the treating physician [7]. The factor analysis pre-
sented by Klok et al. [8] showed that items designated to
social limitations and intensity of complaints had higher
loadings in other dimensions, suggesting that these two
dimensions might not be justifiable. Our factor analysis
supported the formation of three dimensions: limitations
in daily activity (items 4b-m, 5a-d), symptoms (items 1a-
h and 7), and emotional complaints (items 9a-f and j).
Notably, items 6 (Interference with normal social activ-
ities), 8 (Intensity of breathlessness), and 9 g-i (Burden
to family and friends, Afraid to exert yourself, Limited in
taking a trip) were not taken into account in these three
dimensions because these did not contribute signifi-
cantly to either of them. Given that items 6, 8, 9 g, and
9i did not have the highest loadings in the original ver-
sion of the PEmb-QoL either, a possibility would be to
remove items 6, 8, 9 g, and 9i and to replace the original
six dimensions by three dimensions in the French ver-
sion of the questionnaire. As an alternative, items 6, 8,
9 g-i could be grouped into the dimension on which
they loaded highest, i.e. item 6 (Interference with normal
social activities) in symptoms and items 8 (Intensity of
breathlessness) and 9 g-i (Burden to family and friends,
Afraid to exert yourself, Limited in taking a trip) in limi-
tations in daily activity. Either way, further validations of
this adapted PEmb-QoL questionnaire would be neces-
sary. In the Norwegian version of PEmb-QoL question-
naire, an exploratory factor analysis using a different
criterion to determine the number of underlying dimen-
sions (Eigenvalues >1) resulted in six new dimensions
that were not identical with the original version [10]. It
is well known that measurement properties of QoL
questionnaires adapted for a different population may
differ from their original version due to differing transla-
tional, cultural, and methodological factors [11,21,24].
Table 6 Pairwise spearman correlations between SF-36 and PEmb-QoL dimension/summary score*
PEmb-QoL SF-36 physical
functioning
Physical role
functioning
Bodily
pain
General
health
Vitality Social
functioning
Emotional role
functioning
Mental
health
Physical
health
summary
Mental
health
summary
Frequency of
complaints
0.47 0.51 0.68 0.47 0.60 0.56 0.49 0.61 0.49 0.59
ADL limitations 0.90 0.72 0.61 0.57 0.54 0.56 0.64 0.40 0.80 0.39
Work-related
problems
0.62 0.80 0.66 0.47 0.58 0.63 0.59 0.42 0.70 0.46
Social limitations 0.62 0.70 0.61 0.54 0.57 0.69 0.58 0.53 0.64 0.56
Intensity of
complaints
0.59 0.58 0.72 0.50 0.66 0.67 0.51 0.56 0.60 0.58
Emotional complaints 0.53 0.68 0.65 0.55 0.62 0.83 0.71 0.71 0.54 0.76
PEmb-QoL summary
score
0.80 0.77 0.75 0.61 0.69 0.75 0.68 0.60 0.76 0.61
Abbreviations: ADL = Activities of daily living.
*Numbers represent Spearman correlation coefficients (r). The SF-36 summary and dimension scores were reversed for this analysis, i.e. the lower the score, the
better the quality of life. All correlations between dimension/summary scores were statistically significant (P <0.001).
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http://www.hqlo.com/content/12/1/174While items 9 g-i (Burden to family and friends, Afraid
to exert yourself, Limited in taking a trip) were expected
to cluster in the dimension “emotional complaints”, they
clustered in “limitations in daily activity” in our study. A
potential explanation is that the wordings “burden”,
“exert yourself”, and “taking a trip” are not interpreted
as emotional issues but rather as an obstacle to daily ac-
tivity. Given that patients in our cohort were older (63
vs. 56 years) and less likely to have cardiopulmonary co-
morbidity (13% vs. 20%) and obesity (13% vs. 39%) than
patients in the study by Klok et al. [8], we could not ex-
clude the possibility that these differences in patient
baseline characteristics did not contribute to differences
in self-reported health measures.
To facilitate the comparison of PE-related quality of
life across studies, we created an overall PEmb-QoL
summary score using all items, except Q2 (“At what
time of day are your lung symptoms most intense?”) and
Q3 (“Compared to one year ago, how would you rate the
condition of your lungs in general now?”), which were
never scored. This overall score met standard criteria of
acceptability, reliability, reproducibility, and validity forTable 7 Pairwise spearman correlations between PEmb-QoL d
Age Female gender
Frequency of complaints −0.05 0.07
ADL limitations 0.32† −0.08
Work-related problems 0.18 −0.16
Social limitations 0.02 0.01
Intensity of complaints −0.01 −0.06
Emotional complaints −0.10 −0.07
Overall PEmb-QoL summary score 0.12 −0.07
Abbreviations: ADL = Activities of daily living.
*Numbers represent Spearman correlation coefficients (r).
†Correlation with statistical significance (P <0.05).
‡Any cardiac disease with systolic or diastolic ventricular dysfunction or any obstrucuse as a summary patient-reported measure of outcome
in patients with acute PE.
Our study has potential limitations. First, only 42% of
potentially eligible persons with PE completed the ques-
tionnaires, mostly, because they were unreachable or re-
fused to participate. Thus, we could not entirely exclude
the possibility that elderly and sicker patients were un-
derrepresented in our study. However, our enrolment
rate compared well with previous studies, in which less
than 40% of screened patients with VTE underwent
quality of life assessments [10,25]. Second, we could not
ascertain the number of missing items per patient be-
cause missing items were completed by participants fol-
lowing contact by phone with a study collaborator.
However, less than a third of patients had to be con-
tacted because they had one or more missing items. Fi-
nally, we were not able to assess responsiveness of the
PEmb-QoL questionnaire, that is, its ability to detect a
clinically meaningful change over time [8].
In conclusion, despite the presence of some floor and
ceiling effects, the French version of the PEmb-QoL
questionnaire meets standard criteria of reliability andimensions/summary score and baseline characteristics*
Obesity Cancer Cardiopulmonary comorbidity‡
0.21† −0.15 0.03
0.18 −0.07 0.12
−0.02 −0.05 0.17
0.21† −0.12 0.11
0.14 −0.16 0.10
0.13 −0.18 0.13
0.16 −0.15 0.12
tive or restrictive pulmonary disease.
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http://www.hqlo.com/content/12/1/174validity for use as a patient-reported measure of quality
of life and symptoms in patients with PE. Thus, the
French version of the PEmb-QoL can be used with con-
fidence in prospective studies to assess PE-specific qual-
ity of life and symptoms.
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